- « Previous
- Clinical Pharmacology
- Next »
Carafate Tablets
Clinical Pharmacology
Carafate Tablets
In this study, prn antacids were not permitted.
In the other study, scheduled endoscopies were performed at 6 and 12 months, but for-cause endoscopies were permitted as symptoms dictated. Median symptom scores between the sucralfate and placebo groups were not significantly different. A life table intention-to-treat analysis for the 94 patients enrolled in the trial had the following results:
Duodenal Ulcer Recurrence Rate (%)
| Drug | n | 6 months | 12 months |
| CARAFATE | 48 | 19* | 27* |
| Placebo | 46 | 54 | 65 |
| *P<0.002 | |||
In this study, prn antacids were permitted.
Data from placebo-controlled studies longer than 1 year are not available.
Generic Name: Sucralfate
- « Previous
- Clinical Pharmacology
- Next »
GI Disorders
Get the latest treatment options.
Easy GERD Test
Nearly everyone has a little heartburn now and then, but if persistent it can be a sign of something more serious - "GERD". See more WebMD Videos »
